Press Release
Tea Woman Charged with Tampering with Consumer Products and Obtaining Controlled Substances by Fraud
For Immediate Release
U.S. Attorney's Office, District of South Dakota
SIOUX FALLS - United States Attorney Alison J. Ramsdell announced that a federal grand jury has indicted a Tea, South Dakota, woman for Tampering with Consumer Products and Obtaining Controlled Substances by Misrepresentation, Fraud, Forgery, Deception, and Subterfuge.
Brittany Enstad, age 39, was indicted in June of 2023. She appeared before U.S. Magistrate Judge Veronica L. Duffy on June 7, 2023, and pleaded not guilty to the Indictment.
The maximum penalty upon conviction is up to 10 years in federal prison and/or a $250,000 fine, three years of supervised release, and up to $800 to the Federal Crime Victims Fund. Restitution may also be ordered.
The Indictment alleges that between on or about July 1, 2022, and December 30, 2022, Enstad, who was employed as a licensed registered nurse at a medical facility, tampered with blister packs containing OxyContin, Hydrocodone Bitartrate, Oxycodone Hydrochloride, and Oxycodone and Acetaminophen, by removing the medications from their blister packs and replacing them with different medications.
The Indictment also alleges that during the same period of time, Enstad knowingly and intentionally acquired and obtained OxyContin, Hydrocodone Bitartrate, Oxycodone Hydrochloride, and Oxycodone and Acetaminophen, which are all Schedule II controlled substances.
The charges are merely accusations and Enstad is presumed innocent until and unless proven guilty.
The investigation is being conducted by the FDA, DEA, HHS-OIG, and Canton Police Department. Assistant U.S. Attorney Ann M. Hoffman is prosecuting the case.
Enstad was released on bond pending trial, which has not been set.
Updated June 9, 2023
Component